Grampian Biopartners

investment firm

About

Grampian Biopartners is an angel investment group that specialises in seed funding early stage life-science companies.

Highlights

Details

Industries
Asset Management,Impact Investing
Founded date
Mar 1, 2008
Operating Status
Active
Investor Type
Angel Group

GBP was founded in March 2008 by Professor Andy Porter and Drs Keith Charlton and Gillian Broadbent. GBP is an angel investment group that specialises in seed funding early stage life-science companies. Typical investments are of the order of £50-200k. This grouping is unusual because its internationally recognised scientific team is used by other agencies and investment groups to carry out scientific due diligence prior to their investment.GBP became a Scottish co-investment partner on 1st April 2010. To date the company has made ten investments in Scotland and one in a Malaysian company looking to relocate part of its business to Scotland.The company's major commercial and science focus covers immuno-diagnostics and devices, immuno-technology, biologic drug discovery. GBP has particular expertise in the areas of antibody diagnostics and biologic therapeutics. More recently it has also made early stage assessments and investments in regenerative medicine and vaccine/drug delivery companies.

Investments

Number of Investments
Number of Lead Investments
2
0
Grampian Biopartners has made 2 investments. Their most recent investment was on Mar 3, 2016, when NovaBiotics raised £3M.
Date Company Name
Round Money Raised Industry Lead Investor
Mar 3, 2016 NovaBiotics
Series Unknown £3M Biotechnology
Mar 16, 2009 Antoxis
Seed £300K Biotechnology